Magenta Therapeutics Inc. (MGTA) Dropped -5.66% or -0.9 To Price $14.99 On Wednesday


Magenta Therapeutics Inc. (MGTA) dropped -5.66% or -0.9 to $14.99. It is around 41551 shares traded, which is 17.88% compare to the average total volume 232443. The market cap of MGTA is $501.66 million. The year to date change is 159.17%. The 52 week price range is from $5.31 to $21.0. Price of MGTA have changed -1.61% during last week. It have changed -13.92% over last month, 129.62% over last 3 months, 60.83% over last 6 months and 9.44% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MGTA is 14.04. It is -6.34% below current price. The 200-day Moving Averages for MGTA is 11.22. It is -25.15% below current price. The 52-week High is 21.0. It is 40.09% from the current price. The 52-week Low is 5.31. It is -64.58% from current price.

There are some statistics of MGTA. It is has market cap $501.66 million. The share outstanding is 33.47 million. The average volume is 232443. The percent of top 15 Institution holding is 40.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MGTA is -109.38%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MGTA is -55.00%.


Tags:

Share this post